Cargando…

Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists

BACKGROUND: The aim of this study was to evaluate the interobserver variability in diagnosing inflammatory bowel disease (IBD)-associated neoplasia among practicing pathologists from China using telepathology, a practice of remote diagnostic consultation increasingly used nationally and internationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xian-rui, Liu, Hua-shan, Shi, Xue-ying, Zhou, Wei-xun, Jiang, Zhi-nong, Huang, Yan, Karamchandani, Dipti M., Goldblum, John R., Xiao, Shu-yuan, Zhu, Hong-fa, Feely, Michael M., Collinsworth, Amy L., Esnakula, Ashwini, Xie, Hao, Shen, Bo, Lan, Ping, Liu, Xiu-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937390/
https://www.ncbi.nlm.nih.gov/pubmed/29849600
http://dx.doi.org/10.1155/2018/8715263
_version_ 1783320620595937280
author Wu, Xian-rui
Liu, Hua-shan
Shi, Xue-ying
Zhou, Wei-xun
Jiang, Zhi-nong
Huang, Yan
Karamchandani, Dipti M.
Goldblum, John R.
Xiao, Shu-yuan
Zhu, Hong-fa
Feely, Michael M.
Collinsworth, Amy L.
Esnakula, Ashwini
Xie, Hao
Shen, Bo
Lan, Ping
Liu, Xiu-li
author_facet Wu, Xian-rui
Liu, Hua-shan
Shi, Xue-ying
Zhou, Wei-xun
Jiang, Zhi-nong
Huang, Yan
Karamchandani, Dipti M.
Goldblum, John R.
Xiao, Shu-yuan
Zhu, Hong-fa
Feely, Michael M.
Collinsworth, Amy L.
Esnakula, Ashwini
Xie, Hao
Shen, Bo
Lan, Ping
Liu, Xiu-li
author_sort Wu, Xian-rui
collection PubMed
description BACKGROUND: The aim of this study was to evaluate the interobserver variability in diagnosing inflammatory bowel disease (IBD)-associated neoplasia among practicing pathologists from China using telepathology, a practice of remote diagnostic consultation increasingly used nationally and internationally, and its comparison with the interpretation of subspecialized gastrointestinal (GI) pathologists from the United States (US). METHODS: Eight GI pathologists from the US and 4 pathologists from China with an interest in GI pathology participated in this study. A total of 50 colonic biopsies from patients with a clinical history of IBD from 8 medical centers in China were included. All microscopic slides in each case were digitized using an Aperio system. One pathologist (XL) reviewed the digitized full-slide images, and selected areas of interest were captured at low, medium, and high magnifications at a resolution of 1712 × 1072 pixels and saved as tagged image file format (TIFF) files on read-only DVD. Each pathologist evaluated the images and selected the most appropriate diagnostic category for each case (negative, indefinite, low-grade dysplasia [LGD], high-grade dysplasia [HGD], and carcinoma). A Fleiss' kappa coefficient (K) analysis was performed to determine interobserver agreement and the agreement of each pathologist from China with the consensus diagnosis (defined as diagnostic agreement by at least 4 participating US GI pathologists). RESULTS: There was substantial interobserver agreement among 4 pathologists from China on the interpretation of IBD-associated neoplasia (kappa value 0.68, 95% confidence interval: 0.56–0.78). A consensus diagnosis included negative (n = 22), LGD (n = 22), HGD (n = 3), carcinoma (n = 2), and indefinite for dysplasia (n = 1). Using consensus diagnoses as references, the agreement between each pathologist from China and the consensus diagnosis was substantial with kappa values ranging from 0.75 to 0.80. CONCLUSIONS: This study reveals substantial interobserver agreement for the interpretation of colonic neoplasia in IBD using digitized images among Chinese pathologists as well as between each Chinese pathologist and a consensus diagnosis generated by US GI pathologists.
format Online
Article
Text
id pubmed-5937390
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59373902018-05-30 Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists Wu, Xian-rui Liu, Hua-shan Shi, Xue-ying Zhou, Wei-xun Jiang, Zhi-nong Huang, Yan Karamchandani, Dipti M. Goldblum, John R. Xiao, Shu-yuan Zhu, Hong-fa Feely, Michael M. Collinsworth, Amy L. Esnakula, Ashwini Xie, Hao Shen, Bo Lan, Ping Liu, Xiu-li Gastroenterol Res Pract Research Article BACKGROUND: The aim of this study was to evaluate the interobserver variability in diagnosing inflammatory bowel disease (IBD)-associated neoplasia among practicing pathologists from China using telepathology, a practice of remote diagnostic consultation increasingly used nationally and internationally, and its comparison with the interpretation of subspecialized gastrointestinal (GI) pathologists from the United States (US). METHODS: Eight GI pathologists from the US and 4 pathologists from China with an interest in GI pathology participated in this study. A total of 50 colonic biopsies from patients with a clinical history of IBD from 8 medical centers in China were included. All microscopic slides in each case were digitized using an Aperio system. One pathologist (XL) reviewed the digitized full-slide images, and selected areas of interest were captured at low, medium, and high magnifications at a resolution of 1712 × 1072 pixels and saved as tagged image file format (TIFF) files on read-only DVD. Each pathologist evaluated the images and selected the most appropriate diagnostic category for each case (negative, indefinite, low-grade dysplasia [LGD], high-grade dysplasia [HGD], and carcinoma). A Fleiss' kappa coefficient (K) analysis was performed to determine interobserver agreement and the agreement of each pathologist from China with the consensus diagnosis (defined as diagnostic agreement by at least 4 participating US GI pathologists). RESULTS: There was substantial interobserver agreement among 4 pathologists from China on the interpretation of IBD-associated neoplasia (kappa value 0.68, 95% confidence interval: 0.56–0.78). A consensus diagnosis included negative (n = 22), LGD (n = 22), HGD (n = 3), carcinoma (n = 2), and indefinite for dysplasia (n = 1). Using consensus diagnoses as references, the agreement between each pathologist from China and the consensus diagnosis was substantial with kappa values ranging from 0.75 to 0.80. CONCLUSIONS: This study reveals substantial interobserver agreement for the interpretation of colonic neoplasia in IBD using digitized images among Chinese pathologists as well as between each Chinese pathologist and a consensus diagnosis generated by US GI pathologists. Hindawi 2018-04-23 /pmc/articles/PMC5937390/ /pubmed/29849600 http://dx.doi.org/10.1155/2018/8715263 Text en Copyright © 2018 Xian-rui Wu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wu, Xian-rui
Liu, Hua-shan
Shi, Xue-ying
Zhou, Wei-xun
Jiang, Zhi-nong
Huang, Yan
Karamchandani, Dipti M.
Goldblum, John R.
Xiao, Shu-yuan
Zhu, Hong-fa
Feely, Michael M.
Collinsworth, Amy L.
Esnakula, Ashwini
Xie, Hao
Shen, Bo
Lan, Ping
Liu, Xiu-li
Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists
title Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists
title_full Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists
title_fullStr Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists
title_full_unstemmed Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists
title_short Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists
title_sort interobserver agreement in the diagnosis of inflammatory bowel disease-associated neoplasia in china in comparison to subspecialized american gastrointestinal pathologists
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937390/
https://www.ncbi.nlm.nih.gov/pubmed/29849600
http://dx.doi.org/10.1155/2018/8715263
work_keys_str_mv AT wuxianrui interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT liuhuashan interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT shixueying interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT zhouweixun interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT jiangzhinong interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT huangyan interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT karamchandanidiptim interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT goldblumjohnr interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT xiaoshuyuan interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT zhuhongfa interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT feelymichaelm interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT collinsworthamyl interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT esnakulaashwini interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT xiehao interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT shenbo interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT lanping interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists
AT liuxiuli interobserveragreementinthediagnosisofinflammatoryboweldiseaseassociatedneoplasiainchinaincomparisontosubspecializedamericangastrointestinalpathologists